Results
cSCC
Among the 56 patients who signed the consent form, nine did not present high-risk cSCC and other three were already on sirolimus treatment. From the remaining 44 patients, 25 were converted to sirolimus and 19 were kept on CNI-based regimens (12 unsuitable for intervention at the screening visit and seven refusals to conversion; CNI group). During data audit, it was noted that two patients in the SRL group actually did not have high-risk cSCC (protocol deviation). These patients were excluded from the analyses (